CLDX
HealthcareCelldex Therapeutics, Inc.
$25.60
$-1.41 (-5.22%)
Jan 5, 2026
Price History (1Y)
Analysis
Celldex Therapeutics, Inc. is a biotechnology company in the healthcare sector with a market capitalization of $1.70 billion and approximately 186 employees. The company's financial health is marked by significant losses, with a net income of -$224,532,000 and an EBITDA of -$252,858,000 over the trailing twelve months. Margins are also extremely low or negative, with gross margin at 0.0%, operating margin at -9859.2%, and profit margin at 0.0%. Returns on equity and assets are also negative, at -32.4% and -21.8%, respectively. The company's valuation metrics include a forward P/E ratio of -5.81, a price to book of 2.84, and a price to sales of 654.52. The debt-to-equity ratio is 0.44, while the current ratio is 13.01.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.
Visit website →Key Statistics
- Market Cap
- $1.70B
- P/E Ratio
- N/A
- 52-Week High
- $30.50
- 52-Week Low
- $14.40
- Avg Volume
- 821.81K
- Beta
- 1.20
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 186